V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214712 | 20130022 | 1.67 | 80 | null | 2018-03-15 | 2018-04-25 | Trial Unspecified | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100344610 |
| 20214717 | 20130023 | 1.74 | 59.9 | Neo-adjuvant (N) | 2018-04-04 | 2018-04-12 | Sorafenib | 02 | N | OXALIPLATIN + RALTITREXED | 100161978 |
| 20214718 | 20130024 | 1.76 | 67.8 | Palliative (P) | 2017-06-06 | 2017-06-08 | EOX | Y | N | TRIAL | 100390145 |
| 20214719 | 20130025 | 1.52 | 91.6 | Palliative (P) | 2018-02-18 | 2018-02-24 | CETUXIMAB + IRINOTECAN + MDG | 01 | N | OXALIPLATIN + RALTITREXED | 100220145 |
| 20214723 | 20130026 | 1.78 | 68.1 | null | 2020-09-12 | 2020-09-14 | Sorafenib | 02 | null | SORAFENIB | 100412046 |
| 20214724 | 20130027 | null | 68.8 | Palliative (P) | 2018-10-22 | 2019-09-08 | EOX | 01 | N | EOX | 101661613 |
| 20214727 | 20130028 | 1.82 | 54 | Palliative (P) | 2019-06-13 | 2020-01-10 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101290093 |
| 20214728 | 20130029 | null | null | Palliative (P) | 2016-12-16 | 2016-12-16 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100270613 |
| 20214729 | 20130030 | 1.55 | 106.6 | Palliative (P) | 2017-06-08 | 2017-06-08 | Capecitabine 35days + RT | 02 | Y | CAPECITABINE + RT | 101011340 |
| 20214730 | 20130031 | 1.76 | 78 | Palliative (P) | 2019-06-29 | 2019-07-26 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101383168 |
| 20214731 | 20130032 | 1.72 | 80.7 | Adjuvant (A) | 2018-12-29 | 2019-03-07 | Oxaliplatin + Raltitrexed | 99 | N | OXALIPLATIN + RALTITREXED | 100685053 |
| 20214734 | 20130033 | 1.85 | 88.9 | Palliative (P) | 2019-01-04 | 2019-01-18 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100848072 |
| 20214735 | 20130034 | 1.7 | 53.4 | Palliative (P) | 2019-03-31 | 2019-05-17 | EOX | N | N | EOX | 100044984 |
| 20214740 | 20130035 | 1.5 | 69.2 | Palliative (P) | 2019-04-27 | 2019-05-15 | Cetuximab + Oxaliplatin + MdG Maint | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101585486 |
| 20214743 | 20130036 | 1.72 | 63 | Neo-adjuvant (N) | 2017-12-22 | 2019-03-01 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100080495 |
| 20214746 | 20130037 | 1.63 | 69 | Palliative (P) | 2016-07-08 | 2016-07-08 | Oxaliplatin + Raltitrexed | 1 | null | OXALIPLATIN + RALTITREXED | 101587445 |
| 20214747 | 20130038 | 0 | 59 | Palliative (P) | 2016-04-12 | 2016-04-12 | Trial Unspecified | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100230578 |
| 20214748 | 20130039 | 1.79 | null | Palliative (P) | 2020-09-22 | 2020-10-16 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101311090 |
| 20214749 | 20130040 | 1.93 | 54.4 | Curative (C) | 2018-04-04 | 2018-04-25 | Oxaliplatin + Raltitrexed | 01 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100828400 |
| 20214751 | 20130041 | 1.61 | 71.6 | Palliative (P) | 2016-10-09 | 2017-01-21 | EOX | 02 | null | EOX | 101106738 |
| 20214752 | 20130042 | 1.64 | 82.8 | Curative (C) | 2019-05-16 | 2019-06-02 | EOX | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 101586963 |
| 20214753 | 20130043 | 1.75 | 73.3 | Palliative (P) | 2017-05-07 | 2017-06-05 | Trial Unspecified | N | null | CETUXIMAB + IRINOTECAN + MDG | 101057540 |
| 20214758 | 20130044 | 1.83 | 76.8 | Palliative (P) | 2020-07-05 | 2020-07-06 | EOX | N | N | CAPECITABINE + RT | 101584995 |
| 20214759 | 20130045 | 1.84 | 42.5 | Palliative (P) | 2020-09-21 | 2020-10-01 | EOX | 1 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100127898 |
| 20214760 | 20130046 | 1.78 | 71.9 | Adjuvant (A) | 2016-12-10 | 2016-12-11 | Trial Unspecified | Y | N | TRIAL | 101693353 |
| 20214763 | 20130047 | 0 | 74 | Neo-adjuvant (N) | 2018-03-28 | 2018-04-12 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101470973 |
| 20214764 | 20130048 | 0.76 | 59.9 | Neo-adjuvant (N) | 2022-03-07 | 2022-03-15 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101579208 |
| 20214765 | 20130049 | 1.66 | 67 | Palliative (P) | 2017-04-08 | 2017-04-12 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100931637 |
| 20214766 | 20130050 | null | 82.5 | Curative (C) | 2019-10-21 | 2019-10-21 | CETUXIMAB + IRINOTECAN + MDG | N | Y | CETUXIMAB + IRINOTECAN + MDG | 100691289 |
| 20214767 | 20130051 | 1.78 | 86.1 | Palliative (P) | 2016-08-10 | 2016-08-11 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100666150 |
| 20214769 | 20130052 | 1.74 | 65.4 | Palliative (P) | 2019-02-04 | 2019-08-26 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100119992 |
| 20214770 | 20130053 | 1.7 | 60 | Palliative (P) | 2019-09-17 | 2019-10-31 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101565793 |
| 20214771 | 20130054 | 1.5 | 66.4 | null | null | null | CAPECITABINE + RT | N | null | CAPECITABINE + RT | 100555278 |
| 20214772 | 20130055 | 1.88 | 43 | Palliative (P) | 2019-10-08 | 2020-07-18 | Sorafenib | 02 | N | SORAFENIB | 100270949 |
| 20214773 | 20130056 | 1.72 | 68.1 | Palliative (P) | 2019-01-22 | 2019-01-23 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101367434 |
| 20214774 | 20130057 | 1.57 | 67 | Palliative (P) | 2020-01-28 | 2020-02-02 | EOX | 02 | N | TRIAL | 100534976 |
| 20214775 | 20130058 | 1.67 | 0 | Palliative (P) | 2019-04-17 | 2019-05-09 | Panitumumab + Irinotecan + MdG | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101315889 |
| 20214779 | 20130059 | 1.9 | 101 | Palliative (P) | 2018-06-26 | 2018-08-22 | Sorafenib | 02 | Y | SORAFENIB | 100827230 |
| 20214784 | 20130060 | 1.72 | 58.9 | Palliative (P) | 2018-03-17 | 2018-04-01 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100008374 |
| 20214785 | 20130061 | 1.82 | 75.8 | Palliative (P) | 2017-11-09 | 2017-11-10 | EOX | 02 | null | EOX | 100901294 |
| 20214787 | 20130062 | 1.47 | 68.6 | Palliative (P) | 2018-12-09 | 2018-12-13 | IRINOTECAN + MDG + PANITUMUMAB | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101383674 |
| 20214789 | 20130063 | 1.78 | 63.8 | Neo-adjuvant (N) | 2018-04-05 | 2018-04-07 | Trial Unspecified | N | N | EOX | 100123714 |
| 20214792 | 20130064 | 1.57 | 84.25 | Palliative (P) | 2018-02-09 | 2018-02-26 | EOX | Y | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101407417 |
| 20214793 | 20130065 | null | null | null | 2020-10-09 | 2021-01-23 | IRINOTECAN + MDG + PANITUMUMAB | 2 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100041433 |
| 20214794 | 20130066 | 1.62 | 116.6 | Palliative (P) | 2020-06-26 | 2020-06-28 | Trial Unspecified | Y | N | TRIAL | 100717877 |
| 20214798 | 20130067 | 1.55 | 63 | Palliative (P) | 2017-07-07 | 2017-07-15 | Cetuximab + Oxaliplatin + MdG Maint | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100654128 |
| 20214799 | 20130068 | 1.69 | 92 | Palliative (P) | 2018-12-27 | 2019-02-22 | EOX | 02 | N | EOX | 101000117 |
| 20214803 | 20130069 | 1.72 | 73.6 | Palliative (P) | 2017-06-18 | 2017-07-30 | EOX | 02 | N | EOX | 101748652 |
| 20214806 | 20130070 | 1.57 | 75.3 | null | 2020-12-18 | 2020-12-24 | Cetuximab + Oxaliplatin + MdG Maint | 01 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100350957 |
| 20214809 | 20130071 | 1.74 | 68.6 | Palliative (P) | 2018-04-03 | 2018-04-03 | Sorafenib | N | N | SORAFENIB | 101870482 |